Open Scanner

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Agile Thrpe

AGRX
Current price
1.44 USD +0.01 USD (+0.70%)
Last closed 1.43 USD
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
Exchange NASDAQ
Capitalization 9 804 409 USD
Yield for 12 month -45.14 %
1Y
3Y
5Y
10Y
15Y
AGRX
21.11.2021 - 28.11.2021

Agile Therapeutics, Inc., a women's healthcare company, engages in the research, development, and commercialization of prescription contraceptive products for women in the United States. It offers Twirla, a once-weekly prescription combination hormonal contraceptive patch. The company is also developing a pipeline of Twirla line extensions and other products, including AG200-15 Extended Regimen (ER), a regimen that allows a woman to have four episodes of withdrawal bleeding per year; AG200-15 smaller patch (SmP), which is a regimen designed to provide shorter and lighter withdrawal bleeds, and enhance contraceptive efficacy; AG200-15 ER SmP, a regimen to allow a woman to extend the length of her contraceptive cycle, as well as have shorter and lighter withdrawal bleeding episodes per year; and P-Patch, a progestin-only contraceptive patch intended for use by women who are unable or unwilling to take estrogen. Agile Therapeutics, Inc. was incorporated in 1997 and is headquartered in Princeton, New Jersey. Address: 500 College Road East, Princeton, NJ, United States, 08540

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

5 USD

P/E ratio

Dividend Yield

Current Year

+19 593 000 USD

Last Year

+10 884 000 USD

Current Quarter

+5 716 000 USD

Last Quarter

+3 614 000 USD

Current Year

+10 615 000 USD

Last Year

+4 048 000 USD

Current Quarter

+4 036 000 USD

Last Quarter

+1 423 000 USD

Key Figures AGRX

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -15 537 000 USD
Operating Margin TTM -48.23 %
PE Ratio
Return On Assets TTM -75.71 %
PEG Ratio
Return On Equity TTM -1364.04 %
Wall Street Target Price 5 USD
Revenue TTM 21 496 000 USD
Book Value -1.51 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY 49.9 %
Dividend Yield
Gross Profit TTM -6 617 000 USD
Earnings per share -0.52 USD
Diluted Eps TTM -0.52 USD
Most Recent Quarter I 2024
Quarterly Earnings Growth YOY
Profit Margin -36.24 %

Dividend Analytics AGRX

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History AGRX

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor 1:50
Payout Ratio
Last Split Date 11.04.2023
Dividend Date

Stock Valuation AGRX

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE 0.9551
Enterprise Value Revenue 0.1077
Price Sales TTM 0.1274
Enterprise Value EBITDA -0.1667
Price Book MRQ 1.785

Financials AGRX

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators AGRX

For 52 weeks

0.2 USD 3 USD
50 Day MA 0.75 USD
Shares Short Prior Month 213 078
200 Day MA 1.17 USD
Short Ratio 0.28
Shares Short 222 097
Short Percent 7.5 %

Dynamics of changes in the value of assets

M

MON

0.042 EUR Monrif S.p.A +0 (+2.93%)
Detailed analytics
P

PVT

0.018 AUD Pivotal Metals Ltd. -0 (-10%)
Detailed analytics
4

4124

1 487.00 JPY Osaka Yuka Industry Ltd -0.02 (-0.2%)
Detailed analytics
R

REOP

23.00 USD Reo Plastics Inc 0 (0%)
Detailed analytics
P

PKB

1.85 EUR PARK & BELLH - Dusseldorf Stock Exchang 0 (0%)
Detailed analytics